DrugPatentWatch Database Preview
Oliceridine - Generic Drug Details
» See Plans and Pricing
What are the generic sources for oliceridine and what is the scope of patent protection?
Oliceridine
is the generic ingredient in one branded drug marketed by Trevena and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Oliceridine has forty patent family members in twenty-three countries.
Summary for oliceridine
| International Patents: | 40 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 18 |
| Clinical Trials: | 3 |
| Patent Applications: | 58 |
| DailyMed Link: | oliceridine at DailyMed |
Recent Clinical Trials for oliceridine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Trevena Inc. | Phase 3 |
US Patents and Regulatory Information for oliceridine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for oliceridine
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Montenegro | 02754 | Start Trial |
| Portugal | 2688403 | Start Trial |
| Japan | 2014508811 | Start Trial |
| Croatia | P20171021 | Start Trial |
| Eurasian Patent Organization | 201391332 | Start Trial |
| Eurasian Patent Organization | 025456 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
